Cochlear implantation in a patient with a POU4F3 mutation.

Keitaro MiyakeKyoko ShiraiNobuhiro NishiyamaSachie KawaguchiYoko OhtaAtsushi KawanoShin-Ichi UsamiTomohiro KitanoKiyoaki Tsukahara

Published in: Clinical case reports (2020)

Cochlear implants (CIs) are generally considered useful in the treatment of hereditary hearing loss with progressive deafness. Early CI can be beneficial for maintaining social activities in POU4F3 mutation patients.

Keyphrases

hearing loss
end stage renal disease
ejection fraction
chronic kidney disease
multiple sclerosis
mental health
peritoneal dialysis
patient reported outcomes
replacement therapy